Aneuploidy in sclerosing adenosis may predict an increased risk of malignancy. A study using the agNOR silver stain

Pathology

Volumn 29, Issue 3, 1997, Pages 255-259

  Mourad, Walid A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

AgNOR; Breast; Ploidy; Sclerosing adenosis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST HYPERPLASIA; CANCER CYTODIAGNOSIS; CANCER RISK; CELL GRANULE; CELL PROLIFERATION; CHROMOSOME NOR; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PLOIDY; RISK FACTOR; SCLEROSIS; SILVER STAINING; TREATMENT INDICATION;

EID: 0030930046     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169015     Document Type: Article

References (16)

1. Oberman HA, Markey RA. Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 1991; 4: 31-5.
2. Jensen RA, Page DL, Dupont WD, Rogers LW. Invasive cancer risk in women with sclerosing adenosis. Cancer 1989; 64: 1977-83.
3. Carter DJ, Rosen PP. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod Pathol 1991; 4: 1-5.
4. Arden KC, Pathak S, Stettner S, Ritchie E. Differential silver-positive nucleolus organizer region activity in noimal and malignant murine tissues. Cancer Genet Cytogenet 1989; 37: 55-60.
5. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon E, Adnett JJ. Improvement in the staining and the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986; 18: 5-14.
6. Crocker J, Macartney JC, Smith PJ. Correlation between DNA flow cytometry and nucleolar organizer region data in non-Hodgkin's lymphoma. J Pathol 1988; 154: 151-6.
7. Mourad WA, Erkman-Balis B, Livingston S, Shoukri M, Cox CE, Nicosia SV, Rowlands DT. Argyrophilic nucleolar organizer regions in breast carcinoma: correlation with DNA flow cytometry, histopathology and lymph node status. Cancer 1992; 69: 1739-44.
8. Mourad WA, Sembera DL, Katz RL, Atkinson EN, El Naggar AK. Two AgNOR counting methods in fine needle aspirates of lymphoproliferative disorders correlated with acridine orange flow cytometry. Diagn Ctyopathol 1992; 8: 128-34.
9. Mourad WA, Connely JH, Sembera DL, Atkinson EN, Bruner JM. Correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine labeling index: a study of metastatic tumors of the brain. Hum Pathol 1993; 24: 206-10.
10. Mourad WA, Sneige N, Katz RL, Ordonez NG. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma. Diagn Cytopathol 1994; 10: 113-9.
11. Mourad WA, Pugh WC, Huh YO, Keating M. Cell Kinetic analysis of interleukin-2 receptor tested chronic lymphocytic leukemia using the AgNOR silver stain. Am J Clin Pathol 1994; 101: 300-4.
12. Fisher ER, Paleker AS, Kotwal N, Lipana N. A nonencapsulated sclerosing lesion of the breast. Am J Clin Pathol 1979; 71: 240-6.
13. Crocker J, Ayers J, McGovern J. Nucleolar organizer regions in small cell carcinoma of the bronchus. Thorax 1987; 42: 972-5.
14. Crocker J, Skilbeck KN. Nucleolar organizer associated proteins in cutaneous melanocytic lesions: a quantitative study. J Clin Pathol 1987; 40: 885-9.
15. Suresh UR, Cahwner L, Buckley CH, Fox H. Do AgNOR counts reflect cellular ploidy or cellular proliferation? A study of trophoblastic tissue. J Pathol 1990; 160: 213-5.
16. Menden Hall W, Schaffer R, Wackerly D. Mathematical statistics with applications. 3rd ed. Boston: Duxbury Press, 1989; 629-31.